Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Methylhesperidin
1. Methylhesperidin
2. 11013-97-1
3. (2s)-2-(3,4-dimethoxyphenyl)-5-hydroxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one
4. Chebi:81056
5. K324u7386b
6. Dsstox_cid_841
7. Dsstox_rid_75821
8. Dsstox_gsid_20841
9. Methyl Hesperidine
10. Cas-11013-97-1
11. Ccris 4278
12. Mfcd01741310
13. Unii-k324u7386b
14. Chembl3184988
15. Dtxsid7020841
16. Methyl Hesperidin [inci]
17. Methyl Hesperidin [who-dd]
18. Tox21_202328
19. Tox21_302739
20. Zinc79216850
21. Akos015960520
22. Ncgc00249210-01
23. Ncgc00256545-01
24. Ncgc00259877-01
25. Ac-11572
26. C17393
27. A802151
28. Q27155011
29. (2s)-2-(3,4-dimethoxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2h-1-benzopyran-7-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
30. (2s)-2-(3,4-dimethoxyphenyl)-5-hydroxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chroman-4-one;methyl-hesperidin
31. (2s)-2-[3,4-bis(methyloxy)phenyl]-5-hydroxy-4-oxo-3,4-dihydro-2h-chromen-7-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
32. (s)-2-(3,4-dimethoxyphenyl)-5-hydroxy-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)chroman-4-one
33. 28034-80-2
34. 4h-1-benzopyran-4-one, 7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, Monomethyl Ether, (2s)-
35. 4h-1-benzopyran-4-one, 7-((6-o-(6deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3,4-dimethoxyphenyl)-, (2s)-
36. 4h-1-benzopyran-4-one, 7-((6-o-(6deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, Monomethyl Ether, (2s)-
| Molecular Weight | 624.6 g/mol |
|---|---|
| Molecular Formula | C29H36O15 |
| XLogP3 | -0.8 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 8 |
| Exact Mass | 624.20542044 g/mol |
| Monoisotopic Mass | 624.20542044 g/mol |
| Topological Polar Surface Area | 223 Ų |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 956 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Methyl Hesperidin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methyl Hesperidin, including repackagers and relabelers. The FDA regulates Methyl Hesperidin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methyl Hesperidin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methyl Hesperidin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Methyl Hesperidin supplier is an individual or a company that provides Methyl Hesperidin active pharmaceutical ingredient (API) or Methyl Hesperidin finished formulations upon request. The Methyl Hesperidin suppliers may include Methyl Hesperidin API manufacturers, exporters, distributors and traders.
click here to find a list of Methyl Hesperidin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Methyl Hesperidin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methyl Hesperidin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methyl Hesperidin GMP manufacturer or Methyl Hesperidin GMP API supplier for your needs.
A Methyl Hesperidin CoA (Certificate of Analysis) is a formal document that attests to Methyl Hesperidin's compliance with Methyl Hesperidin specifications and serves as a tool for batch-level quality control.
Methyl Hesperidin CoA mostly includes findings from lab analyses of a specific batch. For each Methyl Hesperidin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methyl Hesperidin may be tested according to a variety of international standards, such as European Pharmacopoeia (Methyl Hesperidin EP), Methyl Hesperidin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methyl Hesperidin USP).
LOOKING FOR A SUPPLIER?
